The UK Supreme Court overturned the decision of the High Court and the Court of Appeal that HGS’s patent directed towards Neutrokine, a new protein and member of the ligand superfamily, lacked industrial applicability.

Click here for the full text of this case. A summary of this case will be posted on


To make sure you do not miss out on regular updates from the Kluwer Patent Blog, please subscribe here.

Kluwer IP Law
This page as PDF